KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Long-Term Debt Repayments (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 8 years of Long-Term Debt Repayments data on record, last reported at -$5.6 billion in Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments fell 1642.75% year-over-year to -$5.6 billion; the TTM value through Dec 2025 reached -$2.8 billion, down 1388.22%, while the annual FY2025 figure was -$2.8 billion, 1388.22% down from the prior year.
  • Long-Term Debt Repayments reached -$5.6 billion in Q4 2025 per AMRX's latest filing, down from $2.6 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.6 billion in Q3 2025 and bottomed at -$5.6 billion in Q4 2025.
  • Average Long-Term Debt Repayments over 5 years is -$205.1 million, with a median of $20.3 million recorded in 2021.
  • The widest YoY moves for Long-Term Debt Repayments: up 4586.29% in 2025, down 1642.75% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at -$146.3 million in 2021, then crashed by 56.42% to -$228.9 million in 2022, then tumbled by 147.1% to -$565.6 million in 2023, then skyrocketed by 43.02% to -$322.3 million in 2024, then tumbled by 1642.75% to -$5.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were -$5.6 billion in Q4 2025, $2.6 billion in Q3 2025, and $15.5 million in Q2 2025.